blindness with semaglutide A new study suggests patients taking — the active ingredient in Ozempic and Wegovy — may be at higher risk of developing an eye condition that can cause blindness. Non-arteritic anterior Understanding Semaglutide and Its Impact

What does this mean for the future of GLP-1 treatment

TURN FAT INTO ENERGY Who wouldnt want to turn fat into energy

This consultation can include: A detailed medical evaluation for obesity-related conditions A look into your daily lifestyle A physical exam Weight history (including past weight-loss attempts) A psychological history Many patients come to the clinic with undiagnosed type 2 diabetes, high cholesterol, thyroid disorders, or sleep apnea

You should stop taking Wegovy and seek urgent medical care if you experience severe, persistent abdominal pain (often radiating to the back), with or without vomiting, as this could indicate pancreatitis, a rare but serious side effect of GLP-1 receptor agonists listed in the MHRA SmPC

This central regulation can further modulate hepatic glucose production, although these effects are still being elucidated

The Skin Cancer Foundation reports that just one indoor tanning session before age 35 increases the risk of developing life-threatening melanoma (a type of skin cancer which can spread to other areas of the body) by 75%